We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+8.36%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$143B
AUM Growth
+$17.1B
Cap. Flow
+$6.55B
Cap. Flow %
4.59%
Top 10 Hldgs %
34.23%
Holding
6,117
New
347
Increased
2,011
Reduced
2,450
Closed
668

Sector Composition

Rank Sector Weight
1 Technology 9.43%
2 Healthcare 5.69%
3 Financials 4.7%
4 Consumer Discretionary 4.61%
5 Industrials 3.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CERE
2751
CALL
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$732K ﹤0.01%
30,000
+6,600
+28% +$194K
CERE
2752
PUT
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$732K ﹤0.01%
30,000
+6,600
+28% +$194K
SURF
2753
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$731K ﹤0.01%
1,046,157
PLAY icon
2754
Dave & Buster's
PLAY
$377M
$731K ﹤0.01%
19,868
-7,163
-26% -$286K
CHCT
2755
Community Healthcare Trust
CHCT
$523M
$729K ﹤0.01%
19,908
-5,941
-23% -$232K
RETA
2756
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$728K ﹤0.01%
8,007
+1,259
+19% +$73.9K
PI icon
2757
Impinj
PI
$4.62B
$727K ﹤0.01%
5,368
+523
+11% +$66.7K
MRNS
2758
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$726K ﹤0.01%
105,286
+29,483
+39% +$185K
DNOW icon
2759
DNOW Inc
DNOW
$2.58B
$726K ﹤0.01%
65,123
-13,621
-17% -$171K
MCRB icon
2760
CALL
Seres Therapeutics
MCRB
$46.8M
$725K ﹤0.01%
6,390
+2,915
+84% +$315K
MCRB icon
2761
PUT
Seres Therapeutics
MCRB
$46.8M
$725K ﹤0.01%
6,390
+2,915
+84% +$315K
SHUA
2762
DELISTED
SHUAA Partners Acquisition Corp I Class A Ordinary Share
SHUA
$724K ﹤0.01%
69,130
-8,535
-11% -$88.9K
HLX icon
2763
Helix Energy Solutions
HLX
$1.4B
$721K ﹤0.01%
93,173
-26,599
-22% -$208K
VC icon
2764
Visteon
VC
$2.79B
$721K ﹤0.01%
4,595
-92
-2% -$14.2K
ADNT icon
2765
Adient
ADNT
$1.65B
$719K ﹤0.01%
17,555
-2,619
-13% -$109K
BNL icon
2766
Broadstone Net Lease
BNL
$4.11B
$718K ﹤0.01%
42,222
+7,344
+21% +$128K
HRMY icon
2767
Harmony Biosciences
HRMY
$2.04B
$717K ﹤0.01%
21,946
-6,415
-23% -$292K
SBOW
2768
DELISTED
SilverBow Resources, Inc.
SBOW
$716K ﹤0.01%
31,350
-42,005
-57% -$1.04M
BKE icon
2769
Buckle
BKE
$2.25B
$716K ﹤0.01%
20,053
-3,095
-13% -$127K
LUNG icon
2770
Pulmonx
LUNG
$68.8M
$715K ﹤0.01%
63,995
+19,133
+43% +$189K
TLH icon
2771
iShares 10-20 Year Treasury Bond ETF
TLH
$10.9B
$713K ﹤0.01%
6,223
+3,368
+118% +$379K
VLUE icon
2772
iShares MSCI USA Value Factor ETF
VLUE
$9.17B
$712K ﹤0.01%
7,695
+400
+5% +$37.6K
ZWS icon
2773
Zurn Elkay Water Solutions
ZWS
$8.38B
$711K ﹤0.01%
33,285
+21,451
+181% +$472K
SLCA
2774
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$711K ﹤0.01%
59,525
-8,862
-13% -$105K
VSTO
2775
DELISTED
Vista Outdoor Inc.
VSTO
$710K ﹤0.01%
25,640
-8,806
-26% -$241K

Similar funds

Citigroup's Q1 2023 Portfolio in Review

As of Q1 2023, Citigroup held 6,117 positions worth $143B, up 14% from $126B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Citigroup deployed $6.55B of net new capital in Q1 2023, opening 347 new positions and adding to 2,011 existing holdings. Its largest new stake was Direxion Daily S&P 500 Bull 2X ETF: 350,003 shares worth $28M.

By sector, the portfolio is most concentrated in Technology at 9.4% of assets, down from 9.7% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street Consumer Staples Select Sector SPDR ETF, an estimated $430M trimmed.

  • Citigroup's largest Q1 2023 buy was Direxion Daily S&P 500 Bull 2X ETF: 350,003 shares worth $28M.
  • Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.1B increase.
  • Citigroup's biggest Q1 2023 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $430M.
  • Citigroup fully exited LHC Group LLC in Q1 2023, selling an estimated $28.8M.
  • Citigroup's ten largest holdings make up 34% of its $143B portfolio in Q1 2023.
  • Citigroup opened 347 new positions and closed 668 in Q1 2023.
  • Citigroup's portfolio value rose 14% quarter-over-quarter to $143B.

Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.